SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-021531
Filing Date
2004-04-21
Accepted
2004-04-21 14:04:45
Documents
1
Period of Report
2004-04-19

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP rrd40003.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP rrd40003.xml 4 3828
  Complete submission text file 0001181431-04-021531.txt   5654
Mailing Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405 2034888201
NEUROGEN CORP (Issuer) CIK: 0000849043 (see all company filings)

IRS No.: 222845714 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 PARK AVENUE NEW YORK NY 10022
Business Address 500 PARK AVENUE NEW YORK NY 10022 2129356655
TISCH DANIEL R (Reporting) CIK: 0001111794 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-18311 | Film No.: 04745055